Bio-Works signes distribution agreement with Gene Co. in China including Hong Kong S.A.R. and Macau S.A.R.
Bio-Works Technologies (Nasdaq First North) has signed a distribution agreement with the Hong Kong headquartered Gene Company Ltd to import, store, distribute, market, promote and sell all of its products in China including Hong Kong and Macau Special Administrative Regions.
Bio-Works is continuing the strategy to expand its presence in the Asian region addressing the development of biosimilars and biopharmaceuticals in the Asian countries. China has rapidly progressed from just producing generics and developing biosimilar drugs to R&D focused development of innovative biologics including manufacturing of advanced biopharmaceuticals, with several domestic CDMOs from SMEs to among the world largest including international players, active locally. This agreement will enable Bio-Works to expand its reach on the Chinese market, tapping into Gene Company’s vast coverage of China.
Bio-Works’ third generation proprietary agarose resins, WorkBeads™, with a wide variety of functionalities, WorkBeads affimAb for protein A based affinity, WorkBeads 40Q, 40S and 40 TREN for ion-exchange, size exclusion and WorkBeads 40 IDA and 40 NTA for immobilised metal ion affinity chromatography, are specifically developed with commercial scale manufacturing in mind. WorkBeads generally offers faster mass transport, higher yields and purity than competitors with its stronger and more rigid agarose beads with optimal porosity for antibody based therapies, as well as for peptide and oligo-nucleotide based therapies, and recombinant proteins.
“Bio-Works’ goal is to be a strong alternative for biomanufacturing customers in Asia and this agreement gives us improved access to one of the most important markets, China. Gene Company is a perfect partner that can provide expertise, a strong existing product portfolio and direct contact with customers who would benefit from our products.,” says Mr Mats Johnson, Bio-Works’ CEO.
Gene Comapny has more than 25 years’ experience of distribution of life science products from international partners into China. It has an extensive network of biopharmaceutical customers and a sales force with substantial market knowledge. The company, which is headquartered in Hong Kong, but with large presence in Beijing, Shanghai, Guangzhou and Wuhan, has temperature controlled warehouses around China including one in the FTZ near Shanghai, which facilitates Bio-Works’ commitments of security of supply to its local customers.
“Gene Company is delighted to sign this agreement with Bio-Works and we are excited to promote the high quality resins manufactured by Bio-Works for use in various separation and purification applications. This partnership will surely help us enhance and enrich our business and provide newer products and service to customers says Dr Cheung To, Chairman ofthe Board of Gene Company Ltd.
For more information please visit Bio-Works’ homepage, www.bio-works.com or contact Mr Mats Johnson, CEO for Bio-Works, e-mail: firstname.lastname@example.org, telephone: +46 70 516 53 37.
Bio-Works designs, develops, manufactures and supplies innovative leading edge agarose products for chromatographic separation of proteins, peptidesand other biomolecules. Bio-Works’ agarose based high performance products are used for purificationin the life science research phaseas well as the commercial production of biopharmaceuticals and diagnostic products in large scale. The products are sold globally with our own organization and via distributors.The Bio-Works’ headquarter with R&D and manufacturing is located in Uppsala Business Park in Uppsala, Sweden and the company processes and a Quality Management System follows the standards of ISO 9001:2015. The company’s share is listed on Nasdaq First North. FNCA Sweden AB, +46 (0) 8-528 00 399, email@example.com, is appointed Certified Adviser.
About Gene Co.
Gene Company Ltd is one of the subsidiaries of Gene Group Holding Ltd. (GGH). GGH was founded in 1992 and currently has 18 offices across China and over 650 employees. With more than 25 years of experience in providing the most innovative products, service and solutions to life science community in China. Since establishment, Gene Company Ltd has successfully acquired exclusive distributorships from a number of world-class manufacturers, playing an active and leading role in the life science market.
Mats Johnson, CEO